# RKTO catalysts: Rocket One Inc. PDUFA dates and FDA events

Canonical: https://sec-api.dev/companies/rkto/catalysts

> Rocket One Inc. (RKTO) has no upcoming catalysts in this calendar. The latest recorded is the CLEER-001 interim data readout, April 15, 2025.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: exact day.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Verified answer

### What are the upcoming FDA catalysts for RKTO?

Rocket One Inc. (RKTO) has no upcoming catalysts in this calendar. The latest recorded is the CLEER-001 interim data readout, April 15, 2025. Press release filed with the SEC (EX-99): "York, NY — April 15, 2025 — Hoth Therapeutics, Inc.(NASDAQ: HOTH), a biopharmaceutical company focused on developing innovative therapies for patients with high unmet medical needs, today announced positive interim data from the open-label portion of its Phase 2a clinical trial, CLEER-001, evaluating HT-001 for the treatment of pruritus associated with skin toxicities caused by Epidermal Growth Factor Receptor (EGFR) inhibitors." [Calendar and source filings](https://sec-api.dev/companies/rkto/catalysts)

Source: Press release filed with the SEC (EX-99), accession 0001213900-25-031763, https://www.sec.gov/Archives/edgar/data/1711786/000121390025031763/ea0238201ex99-1_hoth.htm (retrieved 2026-11-12). Last confirmed 2025-04-15. Cite: https://sec-api.dev/companies/rkto/catalysts#answer

## Company

| Field | Value |
| --- | --- |
| Name | Rocket One Inc. |
| Ticker | RKTO (Nasdaq) |
| SEC CIK | 1711786 |
| SIC | 2834 |
| SEC filings | https://sec-api.dev/companies/rkto |

## Cash runway

Cash $6.0M as of 2026-09-30; quarterly burn $2.8M; about 6.5 months of runway at that rate (XBRL company facts, accession 0001213900-26-119676).

## Catalysts

| Date | Event | Ticker | Indication | Status | Source sentence |
| --- | --- | --- | --- | --- | --- |
| December 28, 2022 | [CLEER-001 FDA approval](https://sec-api.dev/pdufa/cleer-001) | RKTO |  | completed, approved | "We received FDA approval to proceed with our clinical study on December 28, 2022." ([SEC Form 10-K](https://www.sec.gov/Archives/edgar/data/1711786/000101376225004108/ea0233805-10k_hoth.htm)) |
| April 15, 2025 | [CLEER-001 interim data readout](https://sec-api.dev/pdufa/cleer-001) | RKTO | high unmet medical needs, today | completed, positive | "York, NY — April 15, 2025 — Hoth Therapeutics, Inc.(NASDAQ: HOTH), a biopharmaceutical company focused on developing innovative therapies for patients with high unmet medical needs, today announced positive interim data from the open-label portion of its Phase 2a clinical trial, CLEER-001, evaluating HT-001 for the treatment of pruritus associated with skin toxicities caused by Epidermal Growth Factor Receptor (EGFR) inhibitors." ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/1711786/000121390025031763/ea0238201ex99-1_hoth.htm)) |

## Drugs

- [CLEER-001](https://sec-api.dev/pdufa/cleer-001): high unmet medical needs, today

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/companies/rkto/catalysts.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "RKTO catalysts: Rocket One Inc. PDUFA dates and FDA events." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/companies/rkto/catalysts

```bibtex
@misc{secapidev_companies_rkto_catalysts_20261116,
  title        = {RKTO catalysts: Rocket One Inc. PDUFA dates and FDA events},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/companies/rkto/catalysts}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_companies_rkto_catalysts_20261116","title":"RKTO catalysts: Rocket One Inc. PDUFA dates and FDA events","publisher":"sec-api.dev","URL":"https://sec-api.dev/companies/rkto/catalysts","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
